The FSA Spy market buzz – 13 December 2024
M&G’s positive outlook; Wisdom from Schroders’s podcast; Alliance Bernstein on the power of curiosity; Janus Henderson on responsible AI; China’s retirement revolution; Apple and much more.
HEAD-TO-HEAD: Janus Henderson vs BNP Paribas Parvest
FSA compares the Janus Global Life Sciences Fund with the Parvest Equity World Health Care Fund
Andrew Acker has been managing the Janus fund since 2007. He was joined in 2016 by Ethan Lovell, who had been a research analyst with the firm since 2007. A key advantage is that both have a science education background: Acker in biochemical sciences and Lovell in chemistry.
“Healthcare is a special industry, compared to other sectors,” said Ng. “You need specialised knowledge. It’s really important to understand the industry before you understand the company. It’s different from the consumer or other sectors.”
“Janus has positioned its team quite well, as many of the analysts have a healthcare industry background,” he added.
Jon Stephenson, the manager of the Parvest fund, joined the firm in 2016. He is supported by a team of four investment specialists. He has 19 years of financial industry experience.
Related Stories
Promoted Content
-
Appetite for thematic investments grows amid rates and inflation concerns
-
Turning environmental hopes into investment reality
-
Despite headwinds, ESG continues to perform
-
China’s post-pandemic growth gathers pace
-
Tap into Japan’s post-pandemic growth trends
-
Driving decarbonisation: how to access new forms of alpha
-
Sustainable Investing in Changing Market Conditions
-
Unmasking the dividend opportunity
-
China bonds: plugging the yield gap
-
Investment Ideas for 2021: Explore the untapped potential in China Small Companies
